Bleeding complications in thrombolytic therapy.
Sherry
S
S
Temple University School of Medicine, Philadelphia.
D000075202:Contraindications; D005341:Fibrinolysin / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy; D012307:Risk Factors; D015912:Thrombolytic Therapy / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D005341:Fibrinolysin